EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
Hacker News·Aug 5·5 min read
Intelligence Is Not the Main Bottleneck
TL;DR
Intelligence, particularly in AI, is often overvalued as a solution to real-world problems, which are frequently hindered by regulatory and political challenges. The author argues that focusing on intelligence alone ignores critical bottlenecks in fields like medicine and housing.
✦ Why It Matters
Evaluate how regulatory frameworks impact your projects and advocate for necessary changes today.
Key Takeaways
- Recognize that intelligence is not the only factor in innovation.
- Assess regulatory impacts on your projects early in development.
- Explore alternative biological targets to avoid target herding.
- Encourage open discussions about AI's limitations within your team.
Full Summary
The discussion highlights that while AI, particularly Artificial General Intelligence (AGI), is often seen as a transformative force, real-world barriers such as regulation and clinical trial processes are significant impediments to progress. For instance, the lengthy and costly nature of clinical trials, which can take over seven years and exceed a billion dollars per drug, illustrates that intelligence alone cannot drive medical advancements.
The article argues that governance issues, such as access to data and regulatory validation, are critical bottlenecks that need addressing. Additionally, the patent system discourages exploration of novel biological targets, leading to a phenomenon known as target herding, where companies focus on already validated targets rather than innovating.
This situation is exacerbated by a monoculture in the San Francisco tech scene, where questioning the transformative potential of AI is often stigmatized, leading to a lack of critical discourse on the actual barriers to technological diffusion.